Showing results (121-130 of 396) with videos related to
Sort By:
Pageof 40
Contemporary Clinical Trials|March 18, 2022
The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE studyZhen Huang, Frank W Rockhold, W Schuyler Jones, et al.Circulation. Cardiovascular Interventions|June 14, 2018
Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve ReplacementAjar Kochar, Zhuokai Li, J Kevin Harrison, et al.Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.Circulation|March 30, 2026
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID TrialsSreekanth Vemulapalli, Karla Pena Guerra, Daniel Wojdyla, et al.JACC. Heart Failure|November 19, 2025
Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and OutcomesJosephine Harrington, Anna Giczewska, Vishal N Rao, et al.Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.Circulation. Cardiovascular Quality and Outcomes|December 10, 2021
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical TrialGuillaume Marquis-Gravel, Bradley G Hammill, Hillary Mulder, et al.Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.Circulation|October 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PADJennifer Rymer, Sonia S Anand, E Sebastian Debus, et al.Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.Pageof 40